
A private investment office with global reach, backing exceptional founders directly, from pre-seed to Series B. Sector and country agnostic, with conviction in applied AI in longevity biotech, robotics, and fintech. Always searching for deep technology and frontier science. I look for founder quality, an unfair edge, and a reason it has to happen now.
Early markers behind the numbers: one exit returned at 1.8x MOIC, one unicorn on the horizon, and one IPO in motion for 2026.
Founder quality first. Valuation discipline. Asymmetric upside. Trust before transaction, and patience long after it.